Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)
Clinical trial NCT02927080 · TERMINATED
Trial details
- NCT number
- NCT02927080
- Sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2019-09-17
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.